CS Medica AS (XSAT:CSMED) Debt-to-Equity : 2.29 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CS Medica AS Debt-to-Equity?

CS Medica AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr2.15 Mil. CS Medica AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr9.11 Mil. CS Medica AS's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr4.92 Mil. CS Medica AS's debt to equity for the quarter that ended in Mar. 2024 was 2.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CS Medica AS's Debt-to-Equity or its related term are showing as below:

XSAT:CSMED' s Debt-to-Equity Range Over the Past 10 Years
Min: -55.03 Med: 0.17 Max: 37.09
Current: 2.29

During the past 5 years, the highest Debt-to-Equity Ratio of CS Medica AS was 37.09. The lowest was -55.03. And the median was 0.17.

XSAT:CSMED's Debt-to-Equity is ranked worse than
96.7% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs XSAT:CSMED: 2.29

CS Medica AS Debt-to-Equity Historical Data

The historical data trend for CS Medica AS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS Debt-to-Equity Chart

CS Medica AS Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Equity

-2.23

37.09

0.07

0.04

0.84

CS Medica AS Quarterly Data
	Sep19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial												0.24	0.44	0.84	1.69	2.29

Competitive Comparison of CS Medica AS's Debt-to-Equity

For the Medical Devices subindustry, CS Medica AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CS Medica AS's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CS Medica AS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CS Medica AS's Debt-to-Equity falls into.

CS Medica AS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CS Medica AS's Debt to Equity Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.192	+	8.587)	/	10.414
	=	0.84

CS Medica AS's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.154	+	9.111)	/	4.922
	=	2.29

CS Medica AS (XSAT:CSMED) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

CS Medica AS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CS Medica AS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CS Medica AS (XSAT:CSMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (XSAT:CSMED) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

8G8:Germany

Address

Fruebjergvej 3, Copenhagen, DNK, 2100

Website

https://www.cs-medica.com

CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis.

CS Medica AS (XSAT:CSMED) Headlines

No Headlines